Measles Cases Surge in US: Experts Blame Trump Administration Response

The number of measles cases in the United States continues to climb, surpassing 1,100 this year, and experts are raising concerns about the response from the Trump administration. Although officials maintain a focus on prevention and treatment, critics point to relaxed messaging, funding cuts, and a perceived downplaying of the outbreak’s severity as contributing factors to the accelerating spread of the highly contagious virus.

A Shift in Tone and Funding

The concerns stem from a series of actions and statements that suggest a diminished emphasis on measles control. In January, the Centers for Disease Control and Prevention (CDC) shifted its recommended childhood vaccine schedule, moving from recommending immunization against 17 diseases to just 11. This decision prompted a lawsuit from 15 states, led by Democratic attorneys general and the governor of Pennsylvania, naming Health and Human Services Secretary Robert F. Kennedy Jr. And CDC Acting Director Jay Bhattacharya as defendants. The plaintiffs argue that reducing the recommended schedule leaves children vulnerable.

Adding to the unease, former CDC principal deputy director Dr. Ralph Abraham reportedly described the dramatic increase in measles cases, and even associated deaths in some states, as simply “the cost of doing business.” Alonzo Plough, chief of science at the Robert Wood Johnson Foundation, found this characterization deeply troubling, suggesting a lack of prioritization within the CDC leadership. While a spokesperson for the Department of Health and Human Services, Andrew G Nixon, refuted claims of deprioritization, stating the CDC’s focus “remains on measles prevention and treatment education and targeted public health interventions,” the perception of a relaxed attitude persists.

Communication Challenges and Conflicting Messages

Experts also highlight a shift in communication strategies. Scott Rivkees, former surgeon general of Florida and now a professor at Brown University’s school of public health, notes that current public health messaging is creating “tremendous confusion,” with senior figures promoting “alternatives” to the measles vaccine – a vaccine widely recognized as safe and effective. This echoes concerns raised in early 2025 regarding misinformation surrounding measles and vitamin A, as reported by CNN.

The CDC’s own communication patterns have also drawn scrutiny. A study by CIDRAP found that CDC social media posts about measles outbreaks were minimal throughout 2025. In one instance, the CDC defended itself against criticism, stating that “framing measles as an American policy failure is inaccurate and misleading,” linking to a letter by Dr. Abraham arguing that vaccination shouldn’t be the sole focus of prevention efforts. While the CDC’s X account recently posted a video of Acting Director Jay Bhattacharya encouraging vaccination, the accompanying text did not explicitly mention vaccines.

The Impact of Funding Cuts on Surveillance

A significant concern is the impact of funding cuts to the CDC, which experts say have hampered disease surveillance and reporting. Jennifer Nuzzo, director of the pandemic center at Brown University, explains that disease surveillance operates like a pyramid, relying on data flow from hospitals to local health departments and ultimately to the national CDC level. Cuts to core CDC staff have slowed this process, leading to delays in reports on morbidity and mortality and a compromised ability to track the full extent of the outbreaks.

These cuts extend to wastewater surveillance, a cost-effective method for estimating case numbers even before clinical detection. Funding for wastewater surveillance, which had been bolstered during the COVID-19 pandemic, is now facing significant reductions, with the Trump administration proposing to cut funding from $125 million to $25 million annually. Nuzzo argues that expanding this funding would be a crucial step in effectively containing measles if the administration were to prioritize the issue.

Restored Funding, Continued Concerns

While Congress recently restored much of the CDC’s funding, as reported by NPR, Plough remains skeptical. He cautions that simply restoring funds doesn’t guarantee they will be allocated effectively. The administration has reportedly sought to pull dollars from state and local health departments, raising further concerns about the capacity to respond to outbreaks at the local level.

The situation in Spartanburg County, South Carolina, which is currently experiencing the most severe measles outbreak in the US, offers a mixed picture. Local health officials are actively ramping up vaccination clinics and public awareness campaigns, demonstrating a proactive response. However, South Carolina requested “non-CDC reinforcements” in its battle against measles, as reported by Reuters, suggesting a need for additional support beyond what the CDC could immediately provide.

The Role of Vaccination

experts emphasize that widespread vaccination remains the most effective way to complete the outbreaks. Nuzzo states plainly: “No amount of surveillance is going to end this, unless people get vaccinated, because the only thing that ends this is immunity.” The CDC reports that 94% of measles cases have occurred among individuals who are unvaccinated or whose vaccination status is unknown, underscoring the critical importance of immunization.

The CDC urges vaccination with the MMR (measles, mumps, and rubella) vaccine. You can find more information about measles and vaccination recommendations on the CDC website. For the latest updates and guidance, consult your healthcare provider and refer to official public health resources.

Looking ahead, the situation will require continued monitoring of case numbers, ongoing surveillance efforts, and a clear and consistent message from public health officials about the importance of vaccination. The effectiveness of these efforts will depend on sustained funding, effective communication, and a commitment to prioritizing the health and safety of the public.